Evidence based medicine: a movement in crisis? - CLL Support

CLL Support

23,137 members39,744 posts

Evidence based medicine: a movement in crisis?

AussieNeil profile image
AussieNeilPartnerAdministrator
0 Replies

An essay by Trisha Greenhalgh of Barts and the London School of Medicine and Dentistry, London and her colleagues and members of the Evidence Based Medicine Renaissance Group, was published last June in the British Medical Journal claiming that there's a crisis in Evidence Based Medicine. This movment, in which "Tradition, anecdote, and theoretical reasoning from basic sciences would be replaced by evidence from high quality randomised controlled trials and observational studies, in combination with clinical expertise and the needs and wishes of patients." started over 20 years ago and has had many successes.

The problems Evidence Based Medicine is currently facing are summarised as follows:

"

- The evidence based “quality mark” has been misappropriated by vested interests

- The volume of evidence, especially clinical guidelines, has become unmanageable

- Statistically significant benefits may be marginal in clinical practice

- Inflexible rules and technology driven prompts may produce care that is management

driven rather than patient centred

- Evidence based guidelines often map poorly to complex multimorbidity

"

bmj.com/content/348/bmj.g3725

I'm sure we'd all like to see more of Real evidence based medicine which:

"

- Makes the ethical care of the patient its top priority

- Demands individualised evidence in a format that clinicians and patients can understand

- Is characterised by expert judgment rather than mechanical rule following

- Shares decisions with patients through meaningful conversations

- Builds on a strong clinician-patient relationship and the human aspects of care

- Applies these principles at community level for evidence based public health

"

David Glance, Director of Innovation, Faculty of Arts, Director of Centre for Software Practice at University of Western Australia, argues that we need data and technology to fix the second problem:

theconversation.com/evidenc...

"Large data sets providing detailed monitoring of patients combined with genetic information will eventually be able to reveal specific information about what makes a treatment work in one patient and not another."

Neil

Written by
AussieNeil profile image
AussieNeil
Partner
To view profiles and participate in discussions please or .

Not what you're looking for?

You may also like...

CLLSA and Leukaemia Care Joint Response to NHS England regarding Ibrutinib Prescribing as per NICE TA

This is the letter sent to Professor Peter Clarke on 2nd July 2018 for the review of Ibrutinib...

What should a Pharmacist's role be in modern medicine?

One of the protective mechanisms with Western/Conventional medicine that is far less common with...

New compendium of quality CLL resources for patients + your hematologist

I am sharing a collection of high quality CLL resources for both patients and hematologists....

Real-World Study Shows Limited Implementation of Reccomended Biomarker Testing in CLL

Targeted Oncology May 4th 2021 In an interview with Targeted Oncology, Dr Mato , a hematologc...

CLL INFORMATION - A developing reliable and current international list of CLL Information & Resources.

We have opened a thread that provides access to many of the key reliable UK and international...